These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35847797)

  • 21. Bartter syndrome prenatal diagnosis based on amniotic fluid biochemical analysis.
    Garnier A; Dreux S; Vargas-Poussou R; Oury JF; Benachi A; Deschênes G; Muller F
    Pediatr Res; 2010 Mar; 67(3):300-3. PubMed ID: 19915517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indomethacin therapy in the treatment of symptomatic polyhydramnios.
    Moise KJ
    Clin Obstet Gynecol; 1991 Jun; 34(2):310-8. PubMed ID: 1868638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios.
    Kirshon B; Mari G; Moise KJ; Wasserstrum N
    J Reprod Med; 1990 May; 35(5):529-32. PubMed ID: 2191133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of indomethacin therapy for polyhydramnios.
    Carmona F; Martínez-Román S; Mortera C; Puerto B; Cararach V; Iglesias X
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(3):175-80. PubMed ID: 8163032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antenatal Bartter syndrome.
    Afzal M; Khan EA; Khan WA; Anwar V; Yaqoob A; Rafiq S; Azam S
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S121-3. PubMed ID: 24906263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bartter syndrome type III and congenital anomalies of the kidney and urinary tract: an antenatal presentation.
    Westland R; Hack WW; van der Horst HJ; Uittenbogaard LB; van Hagen JM; van der Valk P; Kamsteeg EJ; van den Heuvel LP; van Wijk JA
    Clin Nephrol; 2012 Dec; 78(6):492-6. PubMed ID: 23164417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polyhydramnios, prematurity, dystrophy, polyuria, constipation, nephrocalcinosis and renal tumor: presentation of a classic tubulopathy].
    Schnakenburg Cv; Frankenschmidt A; Neumann J; Häffner K; Jeck N; Pohl M
    Klin Padiatr; 2008; 220(1):24-5. PubMed ID: 18172829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe Bartter syndrome type 1: Prompt postnatal management thanks to antenatal identification of SLC12A1 pathogenic variants.
    D'Angelantonio D; Majore S; Di Netta T; Zotta F; Parise G; Savino E; Rosignoli S; Bizzarri B; Signore F; Grammatico P; Bottillo I
    Arch Pediatr; 2022 Oct; 29(7):530-533. PubMed ID: 36058813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bartter syndrome--a rare cause of severe polyhydramnios].
    Media J; Hoseth GE
    Ugeskr Laeger; 2006 Dec; 168(50):4425-6. PubMed ID: 17217871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bartter syndrome in two siblings--antenatal and neonatal observations.
    Proesmans W; Devlieger H; Van Assche A; Eggermont E; Vandenberghe K; Lemmens F; Sieprath P; Lijnen P
    Int J Pediatr Nephrol; 1985; 6(1):63-70. PubMed ID: 3888887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases.
    Allaf B; Dreux S; Schmitz T; Czerkiewicz I; Le Vaillant C; Benachi A; Houfflin-Debarge V; Maréchaud M; Oury JF; Muller F
    Prenat Diagn; 2015 Dec; 35(13):1331-5. PubMed ID: 26426702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indomethacin therapy in the treatment of symptomatic polyhydramnios.
    Kirshon B; Mari G; Moise KJ
    Obstet Gynecol; 1990 Feb; 75(2):202-5. PubMed ID: 2405320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal Bartter syndrome--use of indomethacin in the newborn period and prevention of growth failure.
    Mackie FE; Hodson EM; Roy LP; Knight JF
    Pediatr Nephrol; 1996 Dec; 10(6):756-8. PubMed ID: 8971899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of Bartter syndrome with biochemical examination of amniotic fluid: case report.
    Dane B; Yayla M; Dane C; Cetin A
    Fetal Diagn Ther; 2007; 22(3):206-8. PubMed ID: 17228161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor.
    Kramer WB; Saade GR; Belfort M; Dorman K; Mayes M; Moise KJ
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):396-401. PubMed ID: 9988808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of indomethacin on the pulsatility index of the umbilical artery in human fetuses.
    Moise KJ; Mari G; Kirshon B; Huhta JC; Walsh SW; Cano L
    Am J Obstet Gynecol; 1990 Jan; 162(1):199-202. PubMed ID: 2405675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two neonates with Bartter syndrome.
    Afzal T; Fatima S; Shirazi IH; Halim A
    J Pak Med Assoc; 2018 Nov; 68(11):1721-1723. PubMed ID: 30410160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placental pathology in fetal bartter syndrome.
    Ernst LM; Parkash V
    Pediatr Dev Pathol; 2002; 5(1):76-9. PubMed ID: 11815871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes.
    Konrad M; Leonhardt A; Hensen P; Seyberth HW; Köckerling A
    Pediatrics; 1999 Mar; 103(3):678-83. PubMed ID: 10049979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.